Related Experiment Video
Updated: May 20, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
A simulation platform to examine heterogeneity influence on treatment
Chih-Lin Chi1, Vincent A Fusaro, Prasad Patil
1Center for Biomedical Informatics, Harvard Medical School, Boston, MA.
Summary
Simulating electronic medical records can rapidly assess if warfarin dosing protocols fully integrate patient genetics (CYP2C9, VKORC1) and race. This approach addresses limitations of traditional clinical trials for personalized medicine.
Area of Science:
- Pharmacogenomics
- Clinical Informatics
- Computational Biology
Background:
- Treatment protocols aim for optimal outcomes but individual variability exists due to patient heterogeneity.
- Integrating clinical and genetic factors into treatment recommendations is complex and may not be sufficient for all patient subgroups.
- Traditional clinical trials for evaluating treatment response heterogeneity are time-consuming and costly.
Purpose of the Study:
- To propose and validate a simulation approach using electronic medical records (EMRs) to assess the adequacy of current treatment protocols.
- To determine if warfarin dosing protocols sufficiently integrate patient characteristics, including race and genetic variations (CYP2C9, VKORC1).
- To offer a rapid method for discovering knowledge on treatment outcome variations in specific patient populations.
Main Methods:
- Development of a simulation framework utilizing electronic medical record data.
- Application of the simulation approach to the drug warfarin, a medication with known genetic influences on response.
- Analysis of patient data, focusing on race and the genetic variants CYP2C9 and VKORC1, in relation to warfarin dosing.
Main Results:
- The simulation approach provides a feasible and rapid method for knowledge discovery from EMRs.
- Initial analysis using warfarin suggests potential areas where current protocols may not fully account for genetic and racial variations.
- The study highlights the importance of integrating genetic information (CYP2C9, VKORC1) and race into pharmacogenetic protocols.
Conclusions:
- Simulation using EMRs is a viable alternative to costly clinical trials for evaluating treatment protocol effectiveness.
- Warfarin dosing protocols may require further refinement to fully incorporate the impact of patient race and key genetic factors.
- This methodology can accelerate the advancement of personalized medicine by optimizing treatment strategies for diverse patient populations.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Related Concept Videos
01:23Test for Homogeneity
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:12Statistical Software for Data Analysis and Clinical Trials
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...